HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,584,504 | -28.8% | 78,868 | -23.5% | 0.00% | – |
| Q2 2023 | $3,628,370 | +105.0% | 103,108 | +90.3% | 0.00% | – |
| Q1 2023 | $1,770,000 | +34517.6% | 54,194 | -41.6% | 0.00% | -100.0% |
| Q4 2022 | $5,113 | -99.9% | 92,805 | -20.2% | 0.00% | 0.0% |
| Q3 2022 | $5,150,000 | +8.9% | 116,285 | +19.9% | 0.00% | 0.0% |
| Q2 2022 | $4,729,000 | +283.2% | 96,963 | +282.6% | 0.00% | – |
| Q1 2022 | $1,234,000 | +29.5% | 25,343 | +13.5% | 0.00% | – |
| Q4 2021 | $953,000 | +161.1% | 22,326 | +134.5% | 0.00% | – |
| Q3 2021 | $365,000 | +28.1% | 9,520 | -6.1% | 0.00% | – |
| Q2 2021 | $285,000 | -49.6% | 10,137 | -40.8% | 0.00% | – |
| Q1 2021 | $565,000 | -19.7% | 17,122 | -12.1% | 0.00% | – |
| Q4 2020 | $704,000 | +5766.7% | 19,488 | +4948.7% | 0.00% | – |
| Q3 2020 | $12,000 | – | 386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |